Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR

INTRODUCTION: Cardiovascular benefits observed with new antidiabetic agents may not extend to chronic kidney disease (CKD) patients. This study performed a systematic review and meta-analysis of cardiovascular outcome trials (CVOTs) using new antidiabetic agents stratified by kidney function. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Arshad, Adam, Sarween, Nadia, Sharif, Adnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418973/
https://www.ncbi.nlm.nih.gov/pubmed/34514202
http://dx.doi.org/10.1016/j.ekir.2021.06.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418973/
https://www.ncbi.nlm.nih.gov/pubmed/34514202
http://dx.doi.org/10.1016/j.ekir.2021.06.029

Ejemplares similares